Cargando…
Live Attenuated B. pertussis as a Single-Dose Nasal Vaccine against Whooping Cough
Pertussis is still among the principal causes of death worldwide, and its incidence is increasing even in countries with high vaccine coverage. Although all age groups are susceptible, it is most severe in infants too young to be protected by currently available vaccines. To induce strong protective...
Autores principales: | Mielcarek, Nathalie, Debrie, Anne-Sophie, Raze, Dominique, Bertout, Julie, Rouanet, Carine, Younes, Amena Ben, Creusy, Colette, Engle, Jacquelyn, Goldman, William E, Locht, Camille |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1487175/ https://www.ncbi.nlm.nih.gov/pubmed/16839199 http://dx.doi.org/10.1371/journal.ppat.0020065 |
Ejemplares similares
-
Manufacture of a Stable Lyophilized Formulation of the Live Attenuated Pertussis Vaccine BPZE1
por: Thalen, Marcel, et al.
Publicado: (2020) -
Pertussis (Whooping Cough)
por: Decker, Michael D, et al.
Publicado: (2021) -
Immunogenicity of Live Attenuated B. pertussis BPZE1 Producing the Universal Influenza Vaccine Candidate M2e
por: Kammoun, Hana, et al.
Publicado: (2013) -
Intranasal inoculation with Bordetella pertussis confers protection without inducing classical whooping cough in baboons
por: Naninck, Thibaut, et al.
Publicado: (2021) -
Live Attenuated Pertussis Vaccine BPZE1 Protects Baboons Against Bordetella pertussis Disease and Infection
por: Locht, Camille, et al.
Publicado: (2017)